Clindamycin in 5 Percent Dextrose (Page 5 of 5)
Compatibility
No incompatibility has been demonstrated with the antibiotics cephalothin, kanamycin, gentamicin, penicillin or carbenicillin.
DIRECTIONS FOR USE
Clindamycin in 5% Dextrose Injection in Cryovac Plastic Container
Premixed Clindamycin in 5% Dextrose Injection is for intravenous administration using sterile equipment. Check for minute leaks prior to use by squeezing bag firmly. If leaks are found, discard solution as sterility may be impaired. Do not add supplementary medication. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not use unless solution is clear and seal is intact.
Caution
Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is complete.
Preparation for Administration
- 1.
- Suspend container from eyelet support.
- 2.
- Remove protector from outlet port at bottom of container.
- 3.
- Attach administration set. Refer to complete directions accompanying set.
HOW SUPPLIED
Clindamycin in 5% Dextrose Injection in Cryovac plastic containers is a sterile solution of clindamycin phosphate with 5% dextrose. Each 50 mL contains clindamycin phosphate equivalent to 600 mg or 900 mg clindamycin. The single dose Cryovac plastic containers are available as follows:
600 mg/50 mL, Carton of 24 minibags | NDC 72572-074-24 |
900 mg/50 mL, Carton of 24 minibags | NDC 72572-076-24 |
Exposure of pharmaceutical products to heat should be minimized. It is recommended that Cryovac plastic containers be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Avoid temperatures above 30° C.
REFERENCES
- 1.
- Smith RB, Phillips JP: Evaluation of CLEOCIN HCl and CLEOCIN Phosphate in an Aged Population. Upjohn TR 8147-82-9122-021, December 1982.
Distributed by: Civica, Inc., Lehi, Utah 84043
Manufactured by: InfoRLife SA, Campascio, Switzerland
Rev. June 2022
L128USCLIN02
Package/Label Display Panel
NDC 72572-074 -24
Clindamycin
in 5% Dextrose Injection
600 mg/50 mL
For Intravenous Use
24 x 50 mL Single Dose Containers
CIVICA
Rx Only
Sterile, Nonpyrogenic
Package/Label Display Panel
NDC 72572-076-24
Clindamycin
in 5% Dextrose Injection
900 mg/50 mL
For Intravenous Use
24 x 50 mL Single Dose Containers
CIVICA
Rx Only
Sterile, Nonpyrogenic
CLINDAMYCIN IN 5 PERCENT DEXTROSE clindamycin in 5 percent dextrose injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
CLINDAMYCIN IN 5 PERCENT DEXTROSE clindamycin in 5 percent dextrose injection, solution | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Civica, Inc. (081373942) |
Revised: 06/2022 Civica, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.
https://medlibrary.org/lib/rx/meds/clindamycin-in-5-percent-dextrose/page/5/